Who founded OncoLens?

OncoLens was founded by Anju Mathew in 2017.

Who are OncoLens's investors?

OncoLens's investors include Atlanta Technology Angels, BIP Ventures, Cross-Border Impact Ventures, Martin Ventures, SeedToB, BIP Capital.

How much funding has OncoLens raised?

OncoLens has disclosed $1.4M raised across 1 of its 4 known rounds.

OncoLens

Founded 2017 · 34 employees on LinkedIn · 6 known investors

Find your way into OncoLens

216 people in our graph share verified history with the OncoLens team — schools, employers, funds. One of them is your warm intro.

Jane McCrackenunlockedknows Anju Mathew · together at OncoLens (overlapped)

×6knows the team · via Atlanta Technology Angels

knows the team · via Mayo Clinic Alix School of Medicine

×4knows the team · via Indian Institute of Technology, Roorkee

OncoLens provides a platform that connects cancer care teams and enables multidisciplinary cancer management, helping cancer centers coordinate care, manage tumor boards, and access clinical trials and biomarker testing.

AI & Machine Learning Digital Health Healthtech Medical Devices SaaS

Founders & leadership

OncoLens was founded in 2017 by Anju Mathew.

Anju Mathew Co-Founder and CEOAnju Mathew co-founded and leads OncoLens, a platform for multidisciplinary cancer care coordination and tumor board management. Previously, she served as head of technology and innovation at McKesson's Medical Surgical business unit and founded LumaMed, a medical device company in cancer imaging, with earlier roles at IBM, Thomson-Reuters, A.T. Kearney, and i2 Technologies.

Lijo Simpson Chief Medical OfficerA board-certified medical oncologist who previously worked in clinical research and clinical trials, Lijo Simpson is Chief Medical Officer and co-founder of OncoLens, a platform for multidisciplinary cancer care coordination.

Investors · 6

Atlanta Technology Angelslisted by Atlanta Technology AngelsAtlanta · $200K – $2M

How we know: Atlanta Technology Angels's portfolio page · funding news · businesswire.com · Not right? Tell us

BIP Ventureslisted by BIP VenturesAtlanta

How we know: BIP Ventures's portfolio page · Not right? Tell us

Cross-Border Impact Ventureslisted by Cross-Border Impact VenturesToronto · $2M – $10M

How we know: Cross-Border Impact Ventures's portfolio page · Not right? Tell us

Martin Ventureslisted by Martin VenturesNashville · $2M – $4M

How we know: Martin Ventures's portfolio page · Not right? Tell us

SeedToBlisted by SeedToBSuwanee · $500K – $1.5M

How we know: SeedToB's portfolio page · Not right? Tell us

BIP CapitalreportedAtlanta

How we know: funding news · businesswire.com · Not right? Tell us

Funding

SEC filings, press & company announcements

$1.4M disclosed across 1 of 4 rounds · 2019–2024

Undisclosed amountSeries BOct 2024
Source ↗
Undisclosed amountSeries AJan 2021
Source ↗
$1.4MSeedMar 2019 · 3 sources
Atlanta Technology Angels (lead), BIP Capital (lead)
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does OncoLens do?: OncoLens provides a platform that connects cancer care teams and enables multidisciplinary cancer management, helping cancer centers coordinate care, manage tumor boards, and access clinical trials and biomarker testing.
Who founded OncoLens?: OncoLens was founded by Anju Mathew in 2017.
Who are OncoLens's investors?: OncoLens's investors include Atlanta Technology Angels, BIP Ventures, Cross-Border Impact Ventures, Martin Ventures, SeedToB, BIP Capital.
How much funding has OncoLens raised?: OncoLens has disclosed $1.4M raised across 1 of its 4 known rounds.